tiprankstipranks
Mustang Bio Faces Nasdaq Delisting and Leadership Changes
Company Announcements

Mustang Bio Faces Nasdaq Delisting and Leadership Changes

Pick the best stocks and maximize your portfolio:

Mustang Bio ( (MBIO) ) just unveiled an update.

Mustang Bio, Inc. faces potential delisting from Nasdaq as its stock price remains below $1.00 for over 30 days, though the company has been granted an extension to regain compliance by early 2025. Adding to the uncertainty, James Murphy resigned as Interim CFO, with CEO Manuel Litchman stepping in as his replacement. The company is exploring options to meet Nasdaq’s listing requirements but offers no guarantees of success.

For detailed information about MBIO stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyMustang Bio files to sell 34.77M shares of common stock for holders
TheFlyMustang Bio receives positive listing determination from Nasdaq
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App